Novo Nordisk has sued US rival Eli Lilly, accusing it of false and materially misleading advertising for its weight-loss and anti-diabetes drugs. The Danish company alleges Eli Lilly used outdated clinical trial data to make its treatments appear more effective than Novo's. The legal action was disclosed on Tuesday.
BBC News – Business Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over “false and materially misleading” adverts for its competing weight-loss and anti-diabetes treatments. The Danish pharmaceuticals heavyweight complained that the US group – which makes rival weight-loss treatments Zepboun…
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.
Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over “false and materially misleading” adverts for its competing weight-loss and anti-diabetes treatments. The Danish pharmaceuticals heavyweight complained that the US group – which makes rival weight-loss treatments Zepboun…
BBC News – Business Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.
BBC News – Business Investors pursuing a rescue of Thames Water have offered the UK government a "golden share" that would give it veto power over major decisions and hostile takeovers, in a bid to persuade Andy Burnham not to nationalise the water supplier.
BBC News – Business US President Donald Trump ordered 50% tariffs targeting Canada, escalating trade tensions between the neighbours. Canadian Prime Minister Mark Carney said Ottawa stands ready to deepen trade talks with the United States in response.
